Chitosan and chitosan/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines
- PMID: 9358557
- DOI: 10.1023/a:1012128907225
Chitosan and chitosan/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines
Abstract
Purpose: The aim of this study was to investigate the interaction between the components of novel chitosan (CS) and CS/ethylene oxide-propylene oxide block copolymer (PEO-PPO) nanoparticles and to evaluate their potential for the association and controlled release of proteins and vaccines.
Methods: The presence of PEO-PPO on the surface of the nanoparticles and its interaction with the CS was identified by X-ray photoelectron spectroscopy (XPS). The mechanism of protein association was elucidated using several proteins, bovine serum albumin (BSA), and tetanus and diphtheria toxoids, and varying the formulation conditions (different pH values and concentrations of PEO-PPO), and the stage of protein incorporation into the nanoparticles formation medium.
Results: BSA and tetanus and diphtheria toxoids were highly associated with CS nanoparticles partly due to electrostatic interactions between the carboxyl groups of the protein and the amine groups of CS. PEO-PPO also interacted electrostatically with CS, thus competing with the proteins for association with CS nanoparticles. A visible amount of PEO-PPO was projected towards the outer phase of the nanoparticles. Proteins were released from the nanoparticles at an almost constant rate, the intensity of which was closely related to the protein loading. Furthermore, the tetanus vaccine was released in the active form for at least 15 days.
Conclusions: CS and CS/PEO-PPO nanoparticles prepared by a very mild ionic crosslinking technique are novel and suitable systems for the entrapment and controlled release of proteins and vaccines.
Similar articles
-
Preparation and characterization of polypseudorotaxanes based on block-selected inclusion complexation between poly(propylene oxide)-poly(ethylene oxide)-poly(propylene oxide) triblock copolymers and alpha-cyclodextrin.J Am Chem Soc. 2003 Feb 19;125(7):1788-95. doi: 10.1021/ja026623p. J Am Chem Soc. 2003. PMID: 12580604
-
Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice.Eur J Pharm Biopharm. 2004 Jan;57(1):123-31. doi: 10.1016/j.ejpb.2003.09.006. Eur J Pharm Biopharm. 2004. PMID: 14729088
-
Development and evaluation of chitosan microspheres for tetanus, diphtheria and divalent vaccines: a comparative study of subcutaneous and intranasal administration in mice.Pharm Dev Technol. 2013 Sep-Oct;18(5):1175-85. doi: 10.3109/10837450.2011.618949. Epub 2011 Oct 10. Pharm Dev Technol. 2013. PMID: 21985525
-
Chitosan as a novel nasal delivery system for vaccines.Adv Drug Deliv Rev. 2001 Sep 23;51(1-3):81-96. doi: 10.1016/s0169-409x(01)00171-5. Adv Drug Deliv Rev. 2001. PMID: 11516781 Review.
-
Chitosan and its derivatives in mucosal drug and vaccine delivery.Eur J Pharm Sci. 2001 Oct;14(3):201-7. doi: 10.1016/s0928-0987(01)00172-5. Eur J Pharm Sci. 2001. PMID: 11576824 Review.
Cited by
-
Chitosan nanoparticles as a promising candidate for liver injury induced by 2-nitropropane: Implications of P53, iNOS, VEGF, PCNA, and CD68 pathways.Sci Prog. 2021 Apr-Jun;104(2):368504211011839. doi: 10.1177/00368504211011839. Sci Prog. 2021. PMID: 33940981 Free PMC article.
-
Co-disposition of chitosan nanoparticles by multi types of hepatic cells and their subsequent biological elimination: the mechanism and kinetic studies at the cellular and animal levels.Int J Nanomedicine. 2019 Jul 31;14:6035-6060. doi: 10.2147/IJN.S208496. eCollection 2019. Int J Nanomedicine. 2019. PMID: 31534335 Free PMC article.
-
Preparation and in vivo absorption evaluation of spray dried powders containing salmon calcitonin loaded chitosan nanoparticles for pulmonary delivery.Drug Des Devel Ther. 2013 Aug 28;7:861-73. doi: 10.2147/DDDT.S47681. eCollection 2013. Drug Des Devel Ther. 2013. PMID: 24039397 Free PMC article.
-
Nanovaccine for leishmaniasis: preparation of chitosan nanoparticles containing Leishmania superoxide dismutase and evaluation of its immunogenicity in BALB/c mice.Int J Nanomedicine. 2011;6:835-42. doi: 10.2147/IJN.S16805. Epub 2011 Apr 20. Int J Nanomedicine. 2011. PMID: 21589651 Free PMC article.
-
Synthesis and Characterization of Poly(2-hydroxyethylmethacrylate) Contact Lenses Containing Chitosan Nanoparticles as an Ocular Delivery System for Dexamethasone Sodium Phosphate.Pharm Res. 2016 Jul;33(7):1638-48. doi: 10.1007/s11095-016-1903-7. Epub 2016 Mar 10. Pharm Res. 2016. PMID: 26964548
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical